 Orchard Therapeutics is one of these tickers that, after losing approximately 65 of its value over the past twelve months, has a market cap of around 55M. ORTX has a price-to-book of 0.45 and an enterprise value of about -32M. What is more, ORTX has a price-to-sales of 2.72x. 